Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Language
Publication year range
1.
Transl Vis Sci Technol ; 12(2): 31, 2023 02 01.
Article in English | MEDLINE | ID: mdl-36826843

ABSTRACT

Purpose: The gold standard for managing postoperative ocular fibrosis in glaucoma surgery is the chemotherapeutic mitomycin C (MMC) despite its association with significant adverse effects. This study compares in vitro the antifibrotic efficacy and cytotoxicity of the small-molecule TGFß1 inhibitor SB-431542 (SB) to MMC. Methods: To measure collagen contraction, human Tenon's capsule fibroblasts (HTCFs) embedded in a three-dimensional collagen lattice were exposed to 0.2 mg/mL MMC or 20 µM SB followed by incubation with 2 ng/mL TGFß1. Total protein extracted from experimentally treated HTCFs underwent immunoblotting for α-smooth muscle actin (α-SMA), matrix metallopeptidase 9 (MMP-9), and EDA splice-variant fibronectin (EDA-FN) expression. Cytotoxicity and cell metabolism were assessed using LIVE/DEAD staining, lactate dehydrogenase (LDH) assay, and methylthiazole tetrazolium (MTT) assay. Results: Collagen lattice contraction in TGFß1-induced HTCFs was significantly lowered by SB and MMC. Pretreatment with SB and MMC significantly lowered protein expression of α-SMA, MMP-9, and EDA-FN in HTCFs relative to TGFß1 alone. HTCF viability in collagen lattices was significantly reduced with MMC pretreatment but not SB pretreatment. MMC-pretreated HTCFs had a significant increase in LDH release after 3 hours and a decrease in MTT activity after 20 minutes, while SB-pretreated HTCFs showed no significant changes via MTT or LDH assay during the same treatment period. Conclusions: SB shows comparable efficacy to MMC in reducing expression of fibrosis-promoting proteins in HTCFs and in vitro scarring activity. SB distinguishes itself from MMC by exhibiting less cytotoxicity in both two-dimensional and three-dimensional in vitro assays. Translational Relevance: This study demonstrates in vitro the potential of SB as a safer alternative ocular antifibrotic agent.


Subject(s)
Glaucoma , Mitomycin , Humans , Mitomycin/metabolism , Mitomycin/pharmacology , Tenon Capsule/metabolism , Tenon Capsule/pathology , Cicatrix/metabolism , Matrix Metalloproteinase 9/metabolism , Matrix Metalloproteinase 9/pharmacology , Fibroblasts/metabolism , Fibroblasts/pathology , Collagen , Glaucoma/surgery
2.
J. optom. (Internet) ; 14(4)October - December 2021. graf
Article in English | IBECS | ID: ibc-214567

ABSTRACT

Purpose: To determine the efficacy of prisms when used for redirection of incoming images towards the preferred reinal loci (PRLs) for restitution of potential visual acuity (PVA) in low vision cases with age-related macular degeneration (AMD).MethodsRetrospective comparative interventional case series review. Low vision rehabilitation (LVR) protocol used included best corrected visual acuity (BCVA), PVA, topographic PRL identification and use of prisms to produce image redirection to the presumed PRL. The primary outcome measure selected for analysis was BCVA for viewing distance targets after use of yoke prisms.ResultsImage relocation with prisms in patients with AMD resulted in significantly better BCVA levels (t32 = 8.57, p < 0.0001) in the better eye. Distance BCVA levels achieved were almost identical to PVA levels (t32 = 0.415, p < 0.681) (y= -0.136 + 1.195x, r = 0.8333, p < 0.001).ConclusionsUse of yoke prisms for image redirection towards a peripheral identifiable PRL may result in PVA restitution in most cases. (AU)


Subject(s)
Humans , Macular Degeneration , Vision, Low , Visual Acuity , Rehabilitation , Retrospective Studies
3.
J Optom ; 14(4): 342-345, 2021.
Article in English | MEDLINE | ID: mdl-33478925

ABSTRACT

PURPOSE: To determine the efficacy of prisms when used for redirection of incoming images towards the preferred reinal loci (PRLs) for restitution of potential visual acuity (PVA) in low vision cases with age-related macular degeneration (AMD). METHODS: Retrospective comparative interventional case series review. Low vision rehabilitation (LVR) protocol used included best corrected visual acuity (BCVA), PVA, topographic PRL identification and use of prisms to produce image redirection to the presumed PRL. The primary outcome measure selected for analysis was BCVA for viewing distance targets after use of yoke prisms. RESULTS: Image relocation with prisms in patients with AMD resulted in significantly better BCVA levels (t32 = 8.57, p < 0.0001) in the better eye. Distance BCVA levels achieved were almost identical to PVA levels (t32 = 0.415, p < 0.681) (y= -0.136 + 1.195x, r = 0.8333, p < 0.001). CONCLUSIONS: Use of yoke prisms for image redirection towards a peripheral identifiable PRL may result in PVA restitution in most cases.


Subject(s)
Macular Degeneration , Vision, Low , Humans , Retrospective Studies , Visual Acuity
SELECTION OF CITATIONS
SEARCH DETAIL
...